These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26148290)

  • 1. Anakinra Improves Pyoderma Gangrenosum in Psoriatic Arthritis: A Case Report.
    Acquitter M; Plantin P; Kupfer I; Auvinet H; Marhadour T
    Ann Intern Med; 2015 Jul; 163(1):70-1. PubMed ID: 26148290
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum in a patient with psoriatic arthritis.
    Spangler JG
    J Am Board Fam Pract; 2001; 14(6):466-9. PubMed ID: 11757891
    [No Abstract]   [Full Text] [Related]  

  • 4. Anakinra for recalcitrant pyoderma gangrenosum.
    O'Connor C; Gallagher C; Hollywood A; Paul L; O'Connell M
    Clin Exp Dermatol; 2021 Dec; 46(8):1558-1560. PubMed ID: 34137070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum in association with psoriatic arthritis.
    Smith DL; White CR
    Arthritis Rheum; 1994 Aug; 37(8):1258-60. PubMed ID: 8053964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pyoderma gangrenosum associated with IgA gammopathy with the IL-1 receptor antagonist anakinra.
    Rousset P; Dugourd PM; Lanteri A; Montaudié H; Passeron T
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e447-e450. PubMed ID: 33657262
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene.
    Lin Z; Hegarty JP; Lin T; Ostrov B; Wang Y; Yu W; Kelly AA; Poritz LS; Koltun WA
    Inflamm Bowel Dis; 2011 Jun; 17(6):E41-2. PubMed ID: 21438098
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of pyoderma gangrenosum with anakinra in a patient with Wiskott-Aldrich syndrome.
    Mercuri SR; Paolino G; De Flammineis E; Didona D; Brianti P
    Dermatol Ther; 2018 Mar; 31(2):e12582. PubMed ID: 29214738
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients.
    Beynon C; Chin MF; Hunasehally P; Bhagwandas K; Bevan M; Taylor M; Lawson T
    J Clin Rheumatol; 2017 Apr; 23(3):181-183. PubMed ID: 28333874
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature.
    Zonana-Nacach A; Jiménez-Balderas FJ; Martínez-Osuna P; Mintz G
    J Rheumatol; 1994 Jul; 21(7):1352-6. PubMed ID: 7966084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical uveitis and pyoderma gangrenosum in a patient with psoriatic arthritis under infliximab treatment.
    Fujimoto N; Yamasaki Y; Watanabe R
    J Dtsch Dermatol Ges; 2018 Sep; 16(9):1139-1140. PubMed ID: 30129996
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable expression and treatment of PAPA syndrome.
    Schellevis MA; Stoffels M; Hoppenreijs EP; Bodar E; Simon A; van der Meer JW
    Ann Rheum Dis; 2011 Jun; 70(6):1168-70. PubMed ID: 21325428
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment.
    Caorsi R; Picco P; Buoncompagni A; Martini A; Gattorno M
    J Rheumatol; 2014 Nov; 41(11):2333-4. PubMed ID: 25362725
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
    Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
    Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
    [No Abstract]   [Full Text] [Related]  

  • 15. Anakinra for flares of pyogenic arthritis in PAPA syndrome.
    Dierselhuis MP; Frenkel J; Wulffraat NM; Boelens JJ
    Rheumatology (Oxford); 2005 Mar; 44(3):406-8. PubMed ID: 15637033
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anakinra therapy in a patient with multifocal pyoderma gangrenosum and hidradenitis suppurativa].
    Oymanns M; Kreuter A; Assaf C
    Hautarzt; 2021 May; 72(5):435-438. PubMed ID: 33095334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
    Benzaquen M; Monnier J; Beaussault Y; Rouby F; Berbis P
    Australas J Dermatol; 2017 Nov; 58(4):e270-e271. PubMed ID: 28660635
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Lee WS; Choi YJ; Yoo WH
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):e75-e77. PubMed ID: 27325564
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cutaneous pyoderma gangrenosum with hepatosplenic localization and monoclonal gammapathy. A case report].
    Delbrel X; Germain P; Fach J; Etienne G; Beylot C; Parrens M; De Mascarel A; Le Bras M; Longy-Boursier M
    Ann Med Interne (Paris); 2001 Feb; 152(1):65-7. PubMed ID: 11240430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus.
    Sakamoto T; Hashimoto T; Furukawa F
    Eur J Dermatol; 2002; 12(5):485-7. PubMed ID: 12370142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.